Lundberg Sven Ante [Rocket]

Date	Name	Symbol	Type	Security	Shares	Price	Value	Ownership	Reported
05/26/2023	Vor Biopharma Inc.		Grant	Stock Option (right to buy)	30k	$4.79	$143.7k		05/26/2023
08/22/2022	Merus N.V.	MRUS	Purchase	Common Stock	5.8k	$22.92	$133.6k		08/22/2022
08/19/2022	Merus N.V.	MRUS	Purchase	Common Stock	704	$22.99	$16.2k		08/19/2022
07/12/2022	Merus N.V.	MRUS	Purchase	Common Shares	4.3k	$22.97	$99.7k		07/12/2022
06/14/2022	Vor Biopharma Inc.		Grant	Stock Option (right to buy)	16.9k	$4.26	$72k		06/14/2022
01/31/2022	Merus N.V.	MRUS	Grant	Share Option (right to buy)	295k	$24.61	$7.3M		01/31/2022
03/25/2021	Merus N.V.	MRUS	Gift	Common Shares	74k	$0.00	$0		03/25/2021
03/01/2021	Merus N.V.	MRUS	Exercise	Share Option (right to buy)	63.2k	$13.52	$854.1k		03/01/2021
03/01/2021	Merus N.V.	MRUS	Exercise	Share Option (right to buy)	10.8k	$12.54	$135.8k		03/01/2021
02/16/2021	Merus N.V.	MRUS	Grant	Share Option (right to buy)	368k	$24.43	$9M		02/16/2021
02/05/2021	Vor Biopharma Inc.		Grant	Stock Option (right to buy)	16.9k	$18.00	$304.2k		02/05/2021
01/03/2020	Merus N.V.	MRUS	Grant	Share Option (right to buy)	414.9k	$13.52	$5.6M		01/03/2020
10/24/2016	CRISPR Therapeutics AG	CRSP	Conversion	Series B Preferred Shares	55.2k	$0.00	$0		10/24/2016
10/24/2016	CRISPR Therapeutics AG	CRSP	Purchase	Common Shares	400	$14.00	$5.6k	By wife	10/24/2016
10/24/2016	CRISPR Therapeutics AG	CRSP	Conversion	Common Shares	55.2k	$0.00	$0		10/24/2016